Virtu Financial LLC Genocea Biosciences, Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$0.96 - $1.35 $12,002 - $16,879	-12,503 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$0.95 - $1.99 $11,877 - $24,880	12,503 New	12,503 $15,000
Q3 2021 Nov 12, 2021	SELL	$1.74 - $2.33 $27,187 - $36,406	-15,625 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.06 - $2.82 $32,187 - $44,062	15,625 New	15,625 $37,000
Q3 2020 Dec 11, 2020	SELL	$1.81 - $5.53 $66,401 - $202,873	-36,686 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$1.66 - $3.06 $30,255 - $55,771	18,226 Added 98.73%	36,686 $84,000
Q4 2019 Feb 04, 2020	BUY	$2.05 - $2.82 $37,843 - $52,057	18,460 New	18,460 $38,000
Q3 2019 Nov 20, 2019	SELL	$2.9 - $4.07 $268,667 - $377,061	-92,644 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$3.47 - $6.71 $321,474 - $621,641	92,644 New	92,644 $363,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.